Fresh, sourced stories worth posting about for healthtech founders — updated every few hours, with the receipts attached. Not generated guesses.
Your desk is ready
Free to start · no card required · your pick is waiting on the other side.
Niche's weekly rollup — one email, no spam.
The stories refresh every few hours from live news and primary sources. Each carries the publisher and the date it was published — so you can see exactly how current it is.
Real reporting and primary filings — every story links its sources. Nothing here is a generated guess; the angle is identified and the receipts are attached.
Yes. These are starting points for your own posts. Draft one and Niche writes it in your voice, platform-native, ready to publish.
A cluster of late-stage metabolic and cardiometabolic trials shows continued capital and clinical push into obesity, OSA, type 2 diabetes, diabetic kidney disease, and fatty liver disease. The set spans Novo Nordisk, Regeneron, Lilly, and Sparrow, signaling how metabolic care remains one of the most active therapeutic and commercialization arenas in health care.
Draft a post from this →Several recruiting or completed studies center on respiratory-linked conditions and adjacent care pathways, including OSA, COPD, migraine, and rhinovirus infection. This reflects continued clinical experimentation around sleep-disordered breathing and chronic respiratory management, areas where digital monitoring, adherence, and remote care platforms often play a role.
Draft a post from this →A live discussion thread about companies like Fay, Nourish, Foodsmart, and Berry Street centers on payer access, reimbursement, and employer contract strategy. This is directly relevant to healthtech founders because it captures the commercial realities of scaling digital care models beyond pilot demand into durable payment and distribution channels.
Draft a post from this →NIH projects are looking at aligning hospital admission decisions with patient priorities, renal risk from extreme heat, and pediatric drug kinetics, while other work touches dementia and chronic disease management. Together these point to the growing need for software that supports decision-making, risk stratification, and care coordination across complex settings.
Draft a post from this →Recruiting studies in solid tumors and rare genitourinary cancers highlight precision oncology workflows built around genetic testing, immunotherapy combinations, and targeted therapy selection. For clinical software founders, this cluster reinforces the demand for screening, trial matching, molecular data integration, and oncology coordination infrastructure.
Draft a post from this →